Clinical Research Detail Title Of Study A dose blind extension clinical trial to determine the Long-Term Safety and Efficacy of Two Doses of BG00012 Monotherapy in patients with relapsing remitting multiple sclerosis. Disease Condition Relapsing Remitting Multiple Sclerosis Phase of Trial Phase-3 Discipline Neurology Start date of Trial 2/2/2009 Closing Date of Trial 8/2/2013 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]